|
2022-03-16 |
2022-03-15 |
VP
Vente planifiée
|
Kiraly Thomas E
EVP & Chief Financial Officer
Dirigeant
|
8 750
-3.3%
19,16
167 611 USD
|
8 750
-3.3%
|
19,16
|
167 611 USD
|
|
|
2022-03-08 |
2022-03-08 |
V
Vente
|
Campbell James H
SVP, Chief Clinical Officer
Dirigeant
|
4 000
-7.5%
19,52
78 082 USD
|
4 000
-7.5%
|
19,52
|
78 082 USD
|
|
|
2021-12-17 |
2021-12-16 |
VP
Vente planifiée
|
Kiraly Thomas E
EVP & Chief Financial Officer
Dirigeant
|
8 750
-3.5%
17,30
151 362 USD
|
8 750
-3.5%
|
17,30
|
151 362 USD
|
|
|
2021-09-17 |
2021-09-16 |
VP
Vente planifiée
|
Kiraly Thomas E
EVP & Chief Financial Officer
Dirigeant
|
8 750
-3.4%
21,86
191 307 USD
|
8 750
-3.4%
|
21,86
|
191 307 USD
|
|
|
2021-06-08 |
2021-06-07 |
VP
Vente planifiée
|
ASAR VINIT K
President and CEO
Administrateur exécutif
|
15 000
-1.9%
25,86
387 956 USD
|
15 000
-1.9%
|
25,86
|
387 956 USD
|
|
|
2021-05-04 |
2021-04-30 |
VP
Vente planifiée
|
Adams Gabrielle B.
Vice President Accounting
Dirigeant
|
20 938
-25.9%
25,03
523 988 USD
|
20 938
-25.9%
|
25,03
|
523 988 USD
|
|
|
2021-03-17 |
2021-03-16 |
VP
Vente planifiée
|
Kiraly Thomas E
EVP & Chief Financial Officer
Dirigeant
|
8 750
-3.2%
23,93
209 381 USD
|
8 750
-3.2%
|
23,93
|
209 381 USD
|
|
|
2021-03-11 |
2021-03-10 |
VP
Vente planifiée
|
ASAR VINIT K
President and CEO
Administrateur exécutif
|
15 000
-1.9%
23,22
348 281 USD
|
15 000
-1.9%
|
23,22
|
348 281 USD
|
|
|
2019-12-10 |
2019-12-06 |
V
Vente
|
Adams Gabrielle B.
Vice President Accounting
Dirigeant
|
10 000
-20.2%
26,81
268 129 USD
|
10 000
-20.2%
|
26,81
|
268 129 USD
|
|
|
2019-11-18 |
2019-11-18 |
V
Vente
|
Wendt Jay C
President, Products & Services
Dirigeant
|
5 000
-12.4%
24,00
120 000 USD
|
5 000
-12.4%
|
24,00
|
120 000 USD
|
|
|
2019-11-18 |
2019-11-18 |
V
Vente
|
Wendt Jay C
President, Products & Services
Dirigeant
|
5 000
-11.0%
23,95
119 769 USD
|
5 000
-11.0%
|
23,95
|
119 769 USD
|
|
|
2019-11-18 |
2019-11-18 |
V
Vente
|
Wendt Jay C
President, Products & Services
Dirigeant
|
5 000
-9.9%
23,92
119 591 USD
|
5 000
-9.9%
|
23,92
|
119 591 USD
|
|
|
2019-11-18 |
2019-11-18 |
V
Vente
|
Wendt Jay C
President, Products & Services
Dirigeant
|
4 825
-8.8%
23,87
115 181 USD
|
4 825
-8.8%
|
23,87
|
115 181 USD
|
|
|
2019-11-12 |
2019-11-11 |
V
Vente
|
Campbell James H
SVP, Chief Clinical Officer
Dirigeant
|
2 925
-12.7%
23,81
69 643 USD
|
2 925
-12.7%
|
23,81
|
69 643 USD
|
|
|
2019-08-12 |
2019-08-09 |
V
Vente
|
Wendt Jay C
President, Products & Services
Dirigeant
|
2 860
-7.4%
19,43
55 580 USD
|
2 860
-7.4%
|
19,43
|
55 580 USD
|
|
|
2019-05-13 |
2019-05-10 |
A
Achat
|
ASAR VINIT K
President and CEO
Administrateur exécutif
|
2 700
+0.5%
18,98
51 243 USD
|
2 700
+0.5%
|
18,98
|
51 243 USD
|
|
|
2018-11-14 |
2018-11-13 |
V
Vente
|
Hartman Thomas E
SVP and General Counsel
Dirigeant
|
3 800
-6.3%
19,67
74 758 USD
|
3 800
-6.3%
|
19,67
|
74 758 USD
|
|
|
2018-11-14 |
2018-11-12 |
V
Vente
|
Hartman Thomas E
SVP and General Counsel
Dirigeant
|
2 200
-3.5%
20,26
44 579 USD
|
2 200
-3.5%
|
20,26
|
44 579 USD
|
|
|
2014-08-26 |
2014-08-25 |
A
Achat
|
HARE STEPHEN E
Administrateur non-exécutif
|
1 000
+2.6%
21,98
21 980 USD
|
1 000
+2.6%
|
21,98
|
21 980 USD
|
|
|
2014-08-20 |
2014-08-19 |
A
Achat
|
PETTINGILL RICHARD
Administrateur non-exécutif
|
4 810
+87.9%
20,79
99 980 USD
|
4 810
+87.9%
|
20,79
|
99 980 USD
|
|
